Chul Ho Jung

Title: Chul Ho Jung: Innovator in TNFR-Fc Fusion Protein Technology

Introduction

Chul Ho Jung is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods for preparing TNFR-Fc fusion proteins. His innovative work has implications for therapeutic applications and protein purification processes.

Latest Patents

Chul Ho Jung holds a patent for a "Method for preparing TNFR-Fc fusion protein containing target content of impurities." This invention relates to a method for preparing a TNFR-Fc fusion protein mixture that includes a target content of hydrophobic chromatogram peak 3. The method utilizes a hydrophobic interaction chromatograph medium containing an aromatic functional group, pre-equilibrated with an equilibration buffer comprising sodium chloride or ammonium sulfate. This process is crucial for adjusting the content of hydrophobic chromatogram peak 3, enhancing the efficiency of protein purification.

Career Highlights

Chul Ho Jung is currently employed at LG Chem, Ltd., a leading chemical company known for its advancements in various sectors, including biotechnology. His work at LG Chem has allowed him to focus on innovative solutions in protein engineering and purification.

Collaborations

Chul Ho Jung collaborates with talented coworkers such as Sang Woo Park and Hwa Young Lee. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Chul Ho Jung's contributions to the biotechnology sector, particularly through his patent on TNFR-Fc fusion proteins, highlight his role as an innovator. His work not only advances scientific knowledge but also has practical applications in therapeutic development.